CLINICAL SCIENCE: PDF OnlyProvider Attitudes Regarding Participation of Women and Persons of Color in AIDS Clinical TrialsStone, Valerie E.*†‡; Mauch, Maya Y.†; Steger, Kathleen A.‡Author Information *Division of General Internal Medicine, Department of Medicine, Memorial Hospital of Rhode Island, Brown University School of Medicine, Providence, Rhode Island; †Boston University School of Public Health, Boston, Massachusetts; and ‡Clinical AIDS Program, Department of Medicine, Boston Medical Center, Boston University School of Medicine in Boston, Boston, Massachusetts, U.S.A. Address correspondence and reprint requests to Valerie E. Stone, Division of General Internal Medicine, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI 02860, U.S.A.; email: [email protected]. Preliminary findings of this study were presented in part at the Annual Meeting of the Society of General Internal Medicine, May 1995. Valerie E. Stone is currently affiliated with the Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island, U.S.A. Manuscript received January 7, 1998; accepted May 25, 1998. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology: November 1, 1998 - Volume 19 - Issue 3 - p 245-253 Free Abstract Summary: Provider attitudes and perceptions that may influence recruitment and enrollment of diverse patients into AIDS clinical trials were examined by conducting a cross-sectional survey of all HIV/AIDS providers at a municipal teaching hospital. Providers were less likely to feel confident explaining trials to non-English-speaking patients (p < .05). Providers also reported being more confident of their ability to give an overview of clinical trials in culturally appropriate terms to white patients than to patients of other races/ethnicities (p < .05). Many providers perceived the interest in clinical trials by African American (25%), Latino (14%), and Haitian patients (30%) to be lower; and primarily cited suspicions about clinical research as the reason. Some providers (13%) perceived that women with HIV/AIDS are less interested in clinical trials. Despite these perceptions, all providers reported that they are just as likely to inform women and African Americans about available clinical trials; a small proportion reported that they were less likely to inform Latinos (6%) and Haitians (11%). None of these findings differed significantly by provider race, gender, HIV experience, languages spoken, or specialty. Underrepresentation of minorities and women in AIDS Clinical Trials may partially result from attitudes and perceptions of providers. © 1998 Lippincott Williams & Wilkins, Inc.